abs385.txt	purpose		the	purpose	of	this	study	was	to	compare	outcomes	assessed	in	extantrandomized	controlled	trials	(rcts)	to	outcomes	that	stakeholders	expect	fromsurvivorship	care	plans	(scps)		to	facilitate	the	transition	from	activetreatment	to	follow-up	care	for	the	15	5	million	us	cancer	survivors		manyorganizations	require	scp	use		however		results	of	several	rcts	of	scps'effectiveness	have	been	null		possibly	because	they	have	evaluated	outcomes	onwhich	scps	should	be	expected	to	have	limited	influence		stakeholders	(e	g		survivors		oncologists)	may	expect	outcomes	that	differ	from	rcts'	outcomes	methods		we	identified	rcts'	outcomes	using	a	pubmed	literature	review		weidentified	outcomes	that	stakeholders	expect	from	scps	using	semistructuredinterviews	with	stakeholders	in	three	healthcare	systems	in	the	usa	and	canada	finally		we	mapped	rcts'	outcomes	onto	stakeholder-identified	outcomes	results		rct	outcomes	did	not	fully	address	outcomes	that	stakeholders	expectedfrom	scps		and	rcts	assessed	outcomes	that	stakeholders	did	not	expect	from	scps	rcts	often	assessed	outcomes	only	from	survivors'	perspectives	conclusions		rcts	of	scps'	effectiveness	have	not	assessed	outcomes	thatstakeholders	expect		to	better	understand	scps'	effectiveness		future	rcts	shouldassess	outcomes	of	scp	use	that	are	relevant	from	the	perspective	of	multiplestakeholders	implications	for	cancer	survivors		scps'	effectiveness	may	be	optimized	when	usedwith	an	eye	toward	outcomes	that	stakeholders	expect	from	scps		for	survivors	this	means	using	scps	as	a	map	to	guide	them	with	respect	to	what	kind	offollow-up	care	they	should	seek		when	they	should	seek	it		and	from	whom	theyshould	seek	it	
